Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5197-5209
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5197
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5197
Figure 1 Univariate analysis of the survival rates of colorectal high-grade neuroendocrine neoplasm.
A: Overall survival rate of the entire cohort; B: The cohorts with or without metastatic disease; C: The cohorts categorized by pathologic type; D: The cohorts of age < 70 or ≥ 70. NEC: Neuroendocrine carcinoma; NET: Neuroendocrine tumor; NET G3: Neuroendocrine tumor G3.
- Citation: Wang ZJ, An K, Li R, Shen W, Bao MD, Tao JH, Chen JN, Mei SW, Shen HY, Ma YB, Zhao FQ, Wei FZ, Liu Q. Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals. World J Gastroenterol 2019; 25(34): 5197-5209
- URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5197.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i34.5197